NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
US Patent 10,251,912
Filed on 2016-08-19
Filed on 2016-08-19
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Sweden
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Norway
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
The Netherlands
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Italy
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
United Kingdom
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
France
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Spain
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Denmark
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04